Health Condition 1: F172- Nicotine dependence
Conditions
Interventions
Intervention1: Predefined Homoeopathic medicines
1. Caladium
2. Calcarea phosphoricum
3. Carbo animalis
4. Coca
5. Coffea cruda
6. Daphne indica
7. Eugenia jambos
8. Glonoinum
9. Lycopodium clavatum
and
1000c once in two weeks for 6 weeks.
Each dose consists of 6-8 cane sugar globules no. 20 moistened with the medicine preserved in 90% v/v ethanol
to be taken orally on a clean tongue with an empty stomach.
Along with medicine, the participants will receive standard psychosocial intervention.
Duration of therapy: 6 months
Control Interventio
to be taken orally on clean tongue with empty stomach.
Along with medicine, the participants will receive standard psychosocial intervention.
Duration of therapy: 6 months
The control group will be
Sponsors
DG,Central Council for Research in Homeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants currently using and of continuous use (minimum 05 cigarettes or more) or any other combustible tobacco product. 2. Participants suffering from Nicotine dependence; i.e. currently using the substance (ICD-10 F17.24) and continuous use (ICD-10 F17.25) 3. Participants who score more than 02 marks in the FTND score shall be included in the study. 4. Gender: All Genders. 5. Age 15-65 years. 6. Literate patients; ability to read English or Bengali and/or Hindi. 7. Willing to give informed consent/assent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Participants having mental and behavioral disorder or due to narcotics or psychoactive substance other than Tobacco. 2. Currently and continuous users of smokeless tobacco 3. Other forms of substance abuse and/or dependence 4. Participants on chewable tobacco or any other addictive chewable substances. 5. Patient suffering from mental and behavior disorder due to tobacco, acute intoxication F17.0, Harmful uses F17.1, withdrawal state F17.3 withdrawal state with deliriumF17.4, Psychotic disorder F17.5, Amnesic Syndrome F17.6, Residual & late onset psychotic disorder F17.7 6. Participant suffering from Nicotine dependence who are currently abstinent F17.20, Currently abstinent but in a protracted environment F17.21, Currently on a clinically supervised maintenance or replacement regime [controlled dependence] F17.22, Currently abstinent but receiving treatment with aversive or blocking drugs F17.23, Episodic use F17.26. 7. Participant is already undergoing nicotine replacement therapy. 8. Patient already undergoing homoeopathic treatment for at least 01 Month elsewhere for any chronic disease. 9. Any symptoms suggestive of any serious medical conditions that may require active intervention within 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Degree of dependence on smoking FTND scoreTimepoint: Baseline, every 06 weeks up to 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Urine Cotinine LevelTimepoint: Baseline, after 06 weeks & last follow up (24 weeks);Quit rates & Time to QuitTimepoint: Baseline, every 06 weeks up to 24 weeks;Motivation & Confidence Timepoint: Baseline, every 06 weeks up to 24 weeks. | — |
Countries
India
Contacts
Public ContactDr Gurudev Choubey
Central Council for Research in Homoeopathy New Delhi
Outcome results
None listed